関連する実験動画

Updated: Jul 17, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

III型TGF-β受容体の必要性心臓内臓細胞の変容のために

C B Brown¹, A S Boyer, R B Runyan

¹Department of Pharmacology, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232-6600, USA.

Science (New York, N.Y.)

|March 26, 1999

まとめ

成長因子ベータ受容体 (TBRIII) を変換するIII型受容体は,心臓細胞の変換を局所化する. TBRIIIを阻害することで,メゼンキームの形成と移動を阻害し,TGF-βシグナル伝達におけるメゼンキームの重要な役割を明らかにした.

科学分野:

心血管生物学心血管生物学
細胞シグナル伝達細胞信号伝達
発達生物学発達生物学について

背景:

成長因子ベータ (TGF-β) 信号の変換は心臓発育に不可欠であり,タイプI (TBRI) およびタイプII (TBRII) 受容体によって媒介されます.
TGF-β受容体 (TBRIII) のタイプIIIのTGF-βシグナル伝達における役割は,特に心臓の状況において,定義されたシグナル伝達領域が欠如しているため,依然として十分に理解されていません.

研究の目的:

エピテリア・メゼンキマ変換 (EMT) 中の心臓内皮細胞におけるTBRIIIの機能を調査する.
TBRIIIがTGF-β媒介の心臓発育プロセス,特に心房内膜の形成に作用するかどうかを判断する.

主な方法:

TBRIII特異の抗菌剤を用いて,心臓の拡張性培養における受容体機能を阻害した.
側頭葉のクッションエキスプラントにおけるメゼンキーム形成と細胞移動に対するTBRIII阻害の効果を調べた.
変異しない心室内皮細胞で誤ったTBRIIIを表現し,TGF-β2誘発変異への影響を評価する.

主要な成果:

EMTを受けた心臓内皮細胞でTBRIII発現が観察されました.
特定のアンチセラを使用したTBRIIIの抑制は,心房のクッションエクスプレントにおけるメゼンキームの形成と移住を著しく阻害しました.
静脈内皮細胞におけるTBRIIIの誤発現は,TGF-β2依存型変異を誘導し,応答性の授与における役割を示している.

結論:

TBRIIIは,心臓内のTGF-βシグナル伝達において,重要かつ非冗長な役割を果たします.
TBRIIIの機能は,TGF-β媒介の表皮-メゼンキマの変換を心発達において局所化し,促進する.

さらに関連する動画

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

関連する概念動画

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...